Thursday May 9
Customer Interaction Solutions
Albany Molecular Research Inc - 10-Q - Management's Discussion and...
Forward-Looking Statements The following discussion of our results of operations and financial condition should be read in conjunction with the accompanying Condensed Consolidated Financial Statements and the Notes thereto included within this report.
Wed May 08, 2013
Free Research Reports on AMRI, ARNA, MKTG and SCTY Issued by the Paragon Report
As a leading provider of free in depth reports and timely market updates, Paragon is an essential resource for hundreds of thousands of investors across the country.
Tue May 07, 2013
Albany Molecular Research's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Good day, ladies and gentlemen and welcome to the AMRI First Quarter Earnings Release Conference Call.
AMRI Announces First Quarter 2013 Results And Raises EPS Guidance For The Year
Albany, NY AMRI today reported financial and operating results for the first quarter ended March 31, 2013.
Albany Molecular Research (AMRI) Releases Quarterly Earnings Results
Albany Molecular Research issued its quarterly earnings data on Tuesday. The company reported $0.23 earnings per share for the quarter, StocKRatingsNetwork.com reports.
Fri May 03, 2013
CEO compensation: Lead in tough times, and get paid for it
AMRI co-founder and chief Thomas D'Ambra earned a $300,000 bonus in 2012. He declined it, asking that it go to charity and other AMRI employees.
Tue Apr 30, 2013
SMARTSOURCINGa Continues To Push AMRI Forward
Going into 2012, some analysts wondered about the future of CRO/CMO Albany Molecular Research, Inc.
Mon Apr 29, 2013
Medical campus seeks parking site
Tired of waiting for resolution with preservationists, planners at the Buffalo Niagara Medical Campus are looking at building a second Innovation Center on the site of a city-owned parking ramp at Goodrich and Ellicott.
Fri Apr 26, 2013
AMRI's D'Ambra was paid $3.8 million in 2012
Thomas D'Ambra, CEO of AMRI, earned $3.78 million in 2012. That included $3.18 million in royalty payments from sales of Allegra.
Tue Apr 23, 2013
Albany Molecular Research, Inc. (AMRI) CEO to Present at the 12th Annual Healthcare Conference
Albany Molecular Research, Inc. is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services.